Clinical Trial 14182

Sacramento, CA 95821


Study Summary:

A study of the safety and effectiveness of Rifaximin compared to a placebo in the treatment of IBS-Diarrhea.


Qualified Participants Must:

• Be 18 years of age or older
• For the past 6 months, have experienced at least 3 days per month of pain and discomfort
• Experience soft or watery stool


Qualified Participants May Receive:

Lab testing, study medication or placebo, and up to $400 for completing the study.


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.